Search by Journal
- HOME
- > Search by Journal
- > Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Volume 19, Issue / 2009


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
Nitric oxide synthases in cardiovascular signaling Thomas Michel Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 22-23, 2009. |
---|
![]() |
Examination of action potential prolongation effects of IKr inhibitor and the IKur inhibitor by the A-I-1 human atrium cordis model Shingo Murakami, Kenji in front of the crossroads, 鈴木慎悟, Yoshihisa Kurachi Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 26-26, 2009. |
---|
![]() |
Activated mechanism of the TRPC channel associated with an A-I-2 endothelin type A receptor operation-related Ca2+ inflow Takahiro Horinouchi, Hika class oneself, History of Taku Asano, Nishimoto newly, 西屋禎, Soichi Miwa Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 27-27, 2009. |
---|
![]() |
A-I-3 HSP90 promotes neovascularisation through a cell membrane receptor Yuko Sato, Yoshiko Fujita, Fence field Akemi, Aya Ogura heir, The Iwamoto truth, 善本亮, Tatsuya Sawamura Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 28-28, 2009. |
---|
![]() |
Activated adjustment molecular mechanism of the blood vessel receptor operation-related TRPC6 channel by A-I-4 NO/cGMP/PKG 海琳, 菅忠, Shinichi Takahashi, Satoshi Honda, Masayuki Mori, Takashi Inoue Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 29-29, 2009. |
---|
![]() |
Contribution of the ASK1-p38 MAP kinase transmission course for the molecular mechanism of physiological hypercardia by A-I-5 Exercise training Valley Pond Masayuki, Osamu Yamaguchi, Kinya Otsu Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 30-30, 2009. |
---|
![]() |
The intercellular heterogeneity that switching over time of the calcium release activity to go through A-I-6 ryanodine receptor brings 中村直俊, 山澤徳志子, Yohei Okubo, Masamitsu Iino Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 31-31, 2009. |
---|
![]() |
A-II-1 Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. 石井秀樹, 天野哲也, 松原達昭, 室原豊明 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 32-32, 2009. |
---|
![]() |
Myocardial protection effects through the mitochondrial ATP-dependent potassium channel and phosphatidylinositol 3 kinase of the A-II-2 ghrelin Naoki Inamura, Hirofumi Nishida, Shintaro Harada, Takahiro Tomono, Flower open Takahiro, Akio Matsumoto, Haruaki Nakaya Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 33-33, 2009. |
---|
![]() |
Transplant of endodermis - cardiac muscle cocultivation cell sheet for the A-II-3 emptiness heart failure Shuichi Sekine, Tatsuya Shimizu, Sachiko Sekiya, Masayuki Yamato, Mitsuo Okano Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 34-34, 2009. |
---|
![]() |
The capacity of A-II-4 cardiac muscle cells adjustment is controlled by inositol phospholipid Shintaro Yamamoto 1, 2, 喜多紗斗美 1, Ichijima Kunihiko 2, 頴原嗣尚 2, Takahiro Iwamoto 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 35-35, 2009. |
---|
![]() |
Role of A-II-5 post MI healing process and high-mobility group box 1 protein in the left ventricular remodeling Takashi Kawano 1, Toshihisa Anzai 2, Hiroshi Naito Taro 2, Taku Miyasho 3, Minoru Okamoto 3, Hiroshi Yokota 3, Shingo Yamada 4, Yuichiro Maekawa 2, Takahashi Kotobuki Yuki 2, Tsutomu Yoshikawa 2, Akitoshi Ishizaka 2, Satoshi Ogawa 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 36-36, 2009. |
---|
![]() |
Effect of treatment of pitavastatin for the myocardial remodeling-related molecular change in the A-II-6 many fungosity sepsis mouse model Kengo Tomita 1, 2, Kenichi Takano 1, Makoto Yamamoto person 1, 横尾宏毅 1, Naoyuki Matsuda 3, Noboru Hatakeyama 2, Mitsuaki Yamazaki 2, Yuichi Hattori 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 37-37, 2009. |
---|
![]() |
Cardiovascular cell differentiation instruction and application from person from A-III-1 mechanic pluripotency trunk (iPS) cells Japanese oak Futoshi Sakimoto, Jun Yamashita Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 38-38, 2009. |
---|
![]() |
A-III-2 Hypothalamic paraventricular nucleus in pressor response mechanisms through the brain adrenaline α2 receptor (PVN) in the nervous system involvement 岡本和明, 坂田貴昭, 花房伸幸, 川崎博已 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 39-39, 2009. |
---|
![]() |
A-III-3 Recruitment to the pericytes precursor cells in the brain microvascular network in the central nervous nascent 山本誠士1, 村松昌2, 大澤毅2, 高橋宏行3, 東英梨月1, 4, 堂本光子4, 高野健一1, 生谷尚士5, 長井良憲5, 高津聖志5, 薄井勲6, 戸邉一之6, 新飯田俊平7, 澁谷正史2, 松田直之8, 服部裕一1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 40-40, 2009. |
---|
![]() |
Exhaustive gene expression analysis with the liver after the A-III-4 beta 2 agonist Ritodrine stimulation Yutaka Tsuchiya justice 1, Hidetoshi Tsuda 2, Akio Fujimura 2, 輿水崇鏡 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 41-41, 2009. |
---|
![]() |
The A-III-5 spironolactone inhibits a decrease in peritubular capillary (PTC) of the DOCA/ salt hypertension rat and inhibits tubular stromal fibrosis 岩津好隆 1, Shigeaki Muto 1, Motoo Fujisawa 2, Hideko Nakazawa 1, Eiji Kusano 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 42-42, 2009. |
---|
![]() |
Importance - of tissue renin-angiotensin system activation and the oxidative stress sthenia through cardiac inflammation with the A-III-6 salt / aldosterone and molecular mechanism -ASK1 of the fibrosis promotion Futoshi Nakamura 1, Hisao Ogawa 2, 光山勝慶 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 43-43, 2009. |
---|
![]() |
Analysis of the vasoreactivity in the A-III-7 mouse mesenteric arteries perfusion specimen 和家祥大 1, Hiroki Fujiwara 1, Fusako Takayama 1, Yoshihisa Kitamura 2, Hiromi Kawasaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 44-44, 2009. |
---|
![]() |
It is mouse tumor growth depression effect of Nerve growth factor(NGF) the development of the new antineoplastic agent which assumes perivascular innervation to B-I-1 tumor neovascularity a target 合田光寛 1, Ability tree Saori 1, Keisuke Amitani 1, Yoshihara Narumi 2, Yoshihisa Kitamura 3, Hiromi Kawasaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 45-45, 2009. |
---|
![]() |
The decrease in ferritin heavy chain results in increase of metallic iron and the oxidative stress in B-I-2 cardiac muscle cells and induces cell death Shigeru Omiya trunk, 彦惣俊吾, Kinya Otsu Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 46-46, 2009. |
---|
![]() |
Effect of the adiponectin on migration of vascular smooth muscle cells by B-I-3 IGF-1 Yuki Ishizawa, Keisuke Ishizawa, Motobayashi Yuki, 木平孝高, 池田康将, Shuhei Tomita, Koichiro Tsuchiya, Shun Tamaoki daylight Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 47-47, 2009. |
---|
![]() |
Rho is dependent but the B-I-4 S1P2 receptor inhibits the Rac activity of vascular smooth muscle cells and chemotaxis by a Rho kinase independence-like mechanism through a conjugate to trimeric G protein G12/13 and Gq Shinichiro Takashima, 杉本直俊, Many Hisakazu Noriko, Yasuo Okamoto, Kazuaki Yoshioka, Masayuki Takamura, Shuichi Kaneko, Yo Takuwa Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 48-48, 2009. |
---|
![]() |
Ventricular-Vascular Stiffening in B-I-5 coarctation of the aorta Yoichi Iwamoto, Hideaki Senzaki, Kazuki Kawano, Satoshi Masutani, Hirotaka Ishido, Taketazu non-life, Toshiki Kobayashi Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 49-49, 2009. |
---|
![]() |
It is the examination using vascular smooth muscle cells and vascular endothelial cells pharmacological action of novel compound halichlorine derived from the B-I-6 ocean Description of Tsubosaka justice, Yukihisa Murata, Kazuya Kinoshita, Kaoru Yamada, Daisuke Uemura, Moat Masatoshi, Hiroshi Ozaki Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 50-50, 2009. |
---|
![]() |
Abnormality of the neural vascular reaction in the acute hyperglycemia that assumed B-II-1 postprandial hyperglycemia and hyperinsulinism state Zamami Yoshito 1, 2, Shingo Takatori 1, Gold gold 1, Miho Hosoda 1, Kenji Sasaki 2, Hiromi Kawasaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 51-51, 2009. |
---|
![]() |
B-II-2 Oxidative stress in mononuclear cells plays a dominant role in their adhesion to mouse femoral artery after injury. Sumihiko Hagita 1, 2, Mizuko Osaka 1, 下門顕太郎 2, Masayuki Yoshida 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 52-52, 2009. |
---|
![]() |
About the association that specifically develops in B-II-3 heart chordae tendineae between neovascularisation inhibiting factor Tenomodulin and chordae tendinae rupture onset Shigeru Kimura table 1, 2, 伯野大彦 2, Four Tsu Ryohei 2, Keiichi Fukuda 2 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 53-53, 2009. |
---|
![]() |
B-II-4 Prostaglandin D2 is a tumor vessel neogenesis inhibitor produced by mast cells Yukihisa Murata 1, Existence bamboo Kosuke 2, Takayuki Nakagawa 3, Moat Masatoshi 1, Yoshihiro Urade 2, Hiroshi Ozaki 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 54-54, 2009. |
---|
![]() |
Control structure of the cardiogenesis by B-II-5 sphingosine 1-phosphate (S1P) carrier Spns2 Yu Kuno, Atsuo Kawahara, Akito Yamaguchi, 西毅, Naoki Mochizuki Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 55-55, 2009. |
---|
![]() |
Cardiac activity analysis of the zebra fish heart failure model by the B-II-6 quantitative Cardiac troponin T knockdown Noriko Umemoto 1, 臧黎清 2, Yasuto Shimada 1, 3, 4, Nishimura existence flat 1, 3, 4, 西村訓弘 2, Toshio Tanaka 1, 3, 4 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 56-56, 2009. |
---|
![]() |
Role of the NO synthase system in the etiology of B-III-1 myocardial infarction Yasushi Nakata 1, Masato Tsutsui 2, Hiroaki Shimokawa 3, Yanagihara deferred chapter 4, Tail Yutaka Tsuji 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 57-57, 2009. |
---|
![]() |
The B-III-2 taurine transporter genetic defect mouse develops cardiomyopathy with cardiac muscle cells atrophy Takashi Ito 1, Yasushi Kimura 2, Mika Takai 2, Yoriko Uozumi 2, Satoko Muraoka 2, Shohei Oishi 2, 藤尾慈 2, Junichi Azuma 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 58-58, 2009. |
---|
![]() |
Analysis - obese adipose tissue remodeling and thrombogenesis process ... of the chronic inflammation clinical condition by the molecular imaging in the B-III-3 living body Satoshi Nishimura, Minoru Nagasaki Kei, Ichiro Manabe, Hiroyuki Eto, Ryozo Nagai Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 59-59, 2009. |
---|
![]() |
It is examination using 2 systemic mutant mice the role of mast cells in the B-III-4 mouse viral myocarditis Hirokazu Higuchi 1, 2, Akira Matsumori 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 60-60, 2009. |
---|
![]() |
Than lifesaving rate improvement ... size scale area inclusion study depression Tyne Osaka project after the linked continuous improvement and out-of-hospital cardiac arrest of the B-III-5 lifesaving ... Taku Ishimi, Takashi Kawamura Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 61-61, 2009. |
---|
![]() |
Effect of the calcitonin gene related peptide (CGRP) nerves drying up in the B-III-6 fructose water to drink load-induced insulin resistance model rat Miho Hosoda 1, Kumiko Iwata 1, Zamami Yoshito 2, 川崎博已 1 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 62-62, 2009. |
---|
![]() |
Contribution of FGF2 in the multifaceted effects expression of B-III-7 statin Masayuki Shiota, Yukiko Kawamoto, Yasuo Izumi, Takafumi Nakao, Hiroshi Iwao Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 63-63, 2009. |
---|
![]() |
General No. 1 Dehydroepiandrosterone as Sigma-1 receptor agonist ameliorates pressure overload-induced myocardial hypertrophy and injury in ovariectomized rats (sigma -1 receptor agonist dehydroepiandrosterone inhibits myocardium enlargement and myocardial disorder by the pressure load in an oophorectomy rat.) シェニュアリン ブイヤン, 福永浩司 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 68-68, 2009. |
---|
![]() |
Effect on desmin cardiomyopathy clinical condition of the general No. 2 histone deacetylase (HDAC) inhibitor Atsushi Sanbe, Noriko Miyauchi, Junji Yamauchi, Akito Tanoe Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 69-69, 2009. |
---|
![]() |
Level of expression regulatory mechanism of the endothelin receptor by general No. 3 receptor binding protein Jab1 Nishimoto newly, 西屋禎, Takahiro Horinouchi, Soichi Miwa Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 70-70, 2009. |
---|
![]() |
Takotsubo cardiomyopathy model manufacture using the general No. 4 crab-eating monkey and effect of the beta-blocker Yasuo Izumi, Masayuki Shiota, Takafumi Nakao, Hiroshi Iwao Annual Meeting of Japanese Association of Cardiovascular Pharmacology 19: 71-71, 2009. |
---|